PMDA drug package insert
ファイバ静注用1000
PMDA Prescription drug · 武田薬品工業株式会社 · package insert Jul 1, 2024
Key facts
| Brand names | ファイバ静注用1000 |
|---|---|
| Nonproprietary names | 乾燥人血液凝固因子抗体迂回活性複合体 |
| Companies | 製造販売（輸入）元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 血漿分画製剤 |
| Therapeutic category codes | 876343 |
| YJ codes | 6343414X2058 |
| Approval numbers | 22600AMX01332 |
| Package insert edition | 第2版 |
| Package insert date | Jul 1, 2024 |
| PMDA document key | 400256_6343414X2058_1 |
| PMDA company code | 400256 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: